Point72 Middle East Fze Royalty Pharma PLC Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$26.21 - $29.22 $1.93 Million - $2.15 Million
73,602 Added 186.24%
113,121 $3.18 Million
Q3 2023

Nov 14, 2023
BUY
$26.26 - $31.38 $38,339 - $45,814
1,460 Added 3.84%
39,519 $1.07 Million
Q2 2023

Aug 14, 2023
BUY
$29.6 - $36.56 $355,673 - $439,304
12,016 Added 46.14%
38,059 $1.17 Million
Q1 2023

May 15, 2023
BUY
$32.77 - $39.4 $853,429 - $1.03 Million
26,043 New
26,043 $938,000

Others Institutions Holding RPRX

# of Institutions
412
Shares Held
283M
Call Options Held
578K
Put Options Held
47.5K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email